<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04958213</url>
  </required_header>
  <id_info>
    <org_study_id>MustafaKU-KOA-Prolo</org_study_id>
    <nct_id>NCT04958213</nct_id>
  </id_info>
  <brief_title>The Effect of Dextrose Prolotherapy on Isokinetic Power in the Treatment of Knee Osteoarthritis</brief_title>
  <official_title>Isokinetic Evaluation of the Efficacy of Dextrose Prolotherapy Treatment in Women With Knee Osteoarthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis is a degenerative joint disease characterized by erosion of the articular&#xD;
      cartilage, bone hypertrophy at the margins of the joint, subchondral sclerosis, and some&#xD;
      biochemical and morphological changes in the synovial membrane and joint capsule. It is the&#xD;
      most common joint disease that causes serious morbidity and its prevalence increases with&#xD;
      age. It is known that there is a decrease in the muscle strength around the knee in knee&#xD;
      osteoarthritis, which creates difficulties in daily living activities.&#xD;
&#xD;
      Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal&#xD;
      pain, in which an irritating solution is injected, often hypertonic dextrose, into painful&#xD;
      ligament and tendon attachments and adjacent joint spaces.&#xD;
&#xD;
      In this study, it is aimed to investigate the effect of dextrose prolotherapy application in&#xD;
      and around the knee on pain, range of motion and knee flexor/extensor muscle strength.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">June 20, 2021</completion_date>
  <primary_completion_date type="Actual">June 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS)</measure>
    <time_frame>VAS will be evaluated 3 times before treatment, 1 and 3 months after treatment. Afterwards, the changes between the pre-treatment and 1st month values and the pre-treatment and 3rd month values will be examined.</time_frame>
    <description>10 cm Visual Analogue Scale (0 best, 10 worst pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>WOMAC will be evaluated 3 times before treatment, 1 and 3 months after treatment. Afterwards, the changes between the pre-treatment and 1st month values and the pre-treatment and 3rd month values will be examined.</time_frame>
    <description>A 24-item scale that assesses pain, stiffness, and physical function for knee osteoarthritis. The questions are evaluated by the participants between 0-4 points and the scale takes a value between 0-96 points in total.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee isokinetic power</measure>
    <time_frame>This will be evaluated 3 times before treatment, 1 and 3 months after treatment. Afterwards, the changes between the pre-treatment and 1st month values and the pre-treatment and 3rd month values will be examined.</time_frame>
    <description>Knee flexion and extension strengths will be evaluated with an isokinetic dynamometer.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Dextrose Prolotherapy Injection</condition>
  <condition>Physical Therapy</condition>
  <arm_group>
    <arm_group_label>Conventional physical therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional physical therapy (Hotpack, TENS and Ultrasound) and home exercise program (isometric and isotonic exercises) will be applied to this group for 4 weeks (20 sessions).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose prolotherapy treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will be treated with 15% dextrose prolotherapy around and inside the knee, 2 times with a two-week interval, and home exercise program (isometric and isotonic exercises).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextrose prolotherapy injection</intervention_name>
    <description>15% dextrose prolotherapy injection into the knee and 15% dextrose prolotherapy injection will be applied to the painful adhesions of the ligaments around the knee.</description>
    <arm_group_label>Dextrose prolotherapy treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>conventional physical therapy</intervention_name>
    <description>4 weeks (20 sessions) physical therapy (Hotpack, TENS and Ultrasound) and home exercise program (isometric and isotonic exercises).</description>
    <arm_group_label>Conventional physical therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged 50-75 years&#xD;
&#xD;
          -  2-3 knee osteoarthritis by Kellgren Lawrence stage&#xD;
&#xD;
          -  Knee pain and functional limitation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Past knee surgery&#xD;
&#xD;
          -  Intra articular knee injections in the last six months&#xD;
&#xD;
          -  Symptomatic heart and lung disease&#xD;
&#xD;
          -  Joint contracture&#xD;
&#xD;
          -  History of malignant disease&#xD;
&#xD;
          -  Bleeding disorder&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Knee osteoarthritis is more common in women.</gender_description>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Halil Ogut, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Hatay Mustafa Kemal University Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hatay Mustafa Kemal University Faculty of Medicine</name>
      <address>
        <city>Hatay</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Farpour HR, Fereydooni F. Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: A randomized clinical trial. Electron Physician. 2017 Nov 25;9(11):5663-5669. doi: 10.19082/5663. eCollection 2017 Nov.</citation>
    <PMID>29403602</PMID>
  </results_reference>
  <results_reference>
    <citation>Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, Zgierska A. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013 May-Jun;11(3):229-37. doi: 10.1370/afm.1504. Erratum in: Ann Fam Med. 2013 Sep-Oct;11(5):480.</citation>
    <PMID>23690322</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>July 9, 2021</last_update_submitted>
  <last_update_submitted_qc>July 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>Kamil Mursit Yildiz</investigator_full_name>
    <investigator_title>Research assistant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

